Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT03504956

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03504956
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03504956. Non-randomized; no masking; primary purpose other. Start 2018-07-30 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
Acronym
CATCH
Condition
Coronary Atherosclerosis
Intervention (Device)
Cardiac MRI
Intervention (Drug)
Contrast
Intervention (Drug)
Beta blocker
Lead sponsor
Cedars-Sinai Medical Center (class: other)

Record details

Record id
cardio:ct-nct03504956
Content hash
1d928f5641810536815a5672d3c8c4b06d0e62136fe233eaa1df64857d38cebc